According to the American Migraine Foundation, 12 percent of the American population suffers from migraines and one in every four households in the U.S. has a member with migraines. However, a new treatment technique discovered by a study conducted by Dr. Kenneth Mandato, radiologist at Albany Medical Center in New York, shows promise in reducing the number of American afflicted. The new procedure injects lidocaine, an anesthetic, directly to nerves located at the back of the nasal cavity. One treatment is projected to reduce migraine pain levels by 35 percent and is minimally invasive.
Dr. Mandato says,
Migraine headaches are one of the most common, debilitating diseases in the United States, and the cost and side effects of medicine to address migraines can be overwhelming… Intranasal sphenopalatine ganglion blocks are image-guided, targeted, breakthrough treatments… They offer a patient-centered therapy that has the potential to break the migraine cycle and quickly improve patients’ quality of life.”
The procedure was tested in a group of 112 patients of whom the average age was 45 years old. The average pain score for the group as a whole stood above or around eight (on a scale of one to ten) prior to treatment. After the first day of the procedure, the group score dropped from eight to about 5. Six percent of patients remained unimproved.
Dr. Richard Lipton, director of the Montefiore Center in New York City, says,
These results sound very promising… Of course, it remains to be seen if the demonstrated benefit already seen holds up over a longer period of time, and with a bigger group of patients.”
The researchers plan to continue to track the responses of the 112 patients to gauge their responses 6 months after treatment.
Read more here- “Simply New Treatment Option for Migraine Sufferers,” (Alan Mozes, HealthDay)